Wortmannin and LY294002 act as PI3K inhibitors, targeting a key node in cell survival and proliferation pathways, which can alter the function of downstream proteins such as LOC729693. Inhibition by these compounds leads to a reduction in the phosphorylation and activation of proteins associated with the PI3K/Akt pathway. MAP kinase pathway inhibitors, including SB203580, PD98059, U0126, and CI-1040, can hinder the MAPK/ERK pathway, affecting proteins that are regulated by this signaling cascade. These inhibitors can impact cell differentiation, proliferation, and survival signals, leading to an alteration in the activity of proteins like LOC729693. The JNK inhibitor SP600125 and the p38 MAP kinase inhibitor SB203580 can disrupt stress and inflammatory response pathways, which may affect LOC729693 if it is a protein that responds to cellular stress stimuli.
Rapamycin and Bortezomib target the mTOR pathway and the proteasome, respectively. Rapamycin's inhibition of mTORC1 signaling can decrease the synthesis of proteins, while Bortezomib can lead to an accumulation of proteins by preventing their degradation. Both mechanisms can influence the levels and activity of proteins such as LOC729693. Gefitinib and Dasatinib, as inhibitors of tyrosine kinases like EGFR and Src, can have broad effects on cell communication and signaling pathways, potentially altering the activity of proteins governed by these kinases, including LOC729693.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can suppress the PI3K/Akt pathway, possibly reducing the activity of proteins regulated by this pathway, including LOC729693. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor that can disrupt inflammatory and stress response pathways, potentially decreasing the activity of proteins like LOC729693 that are modulated by these pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that can prevent phosphorylation and activation of downstream targets, possibly affecting proteins like LOC729693 involved in cell survival signals. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can impair the MAPK/ERK pathway, potentially affecting proteins like LOC729693 that may be regulated through this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can suppress mTORC1 signaling, potentially influencing the synthesis and activity of proteins like LOC729693. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Selective inhibitor of both MEK1 and MEK2, which can alter the MAPK/ERK pathway, potentially affecting the activity of LOC729693. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can disrupt the JNK signaling pathway, potentially altering the activity of proteins like LOC729693 that could be regulated by this pathway. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor that can impede the EGFR signaling pathway, potentially affecting proteins like LOC729693 involved in this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family tyrosine kinase inhibitor that can alter signal transduction pathways, potentially affecting the activity of proteins like LOC729693. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can prevent the degradation of proteins, potentially influencing the levels of proteins like LOC729693. | ||||||